About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
Division of Hematology/Oncology
›
top-articles
Division of Hematology/Oncology
148
(top 1%)
papers
7.0K
(top 1%)
citations
35
(top 1%)
h
-index
84
(top 1%)
g
-index
153
all documents
7.5K
doc citations
1.5K
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
Molecular Cancer Therapeutics
2017
1,779
2
Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell–derived factor-1
Blood
2000
648
3
Lineage-Specific Hematopoietic Growth Factors
New England Journal of Medicine
2006
423
4
CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia
Blood
2000
318
5
Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1
Blood
2000
308
6
International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease
Blood
2018
232
7
Development of lentiviral vectors for gene therapy for human diseases
Blood
2000
226
8
Distinctive features of “nurselike” cells that differentiate in the context of chronic lymphocytic leukemia
Blood
2002
223
9
Ig VH1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features.
Journal of Immunology
1997
162
10
Fibroblast-like synoviocytes support B-cell pseudoemperipolesis via a stromal cell–derived factor-1– and CD106 (VCAM-1)–dependent mechanism
Journal of Clinical Investigation
2001
156
11
Ig VH1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features
Journal of Immunology
1997
146
12
On the molecular origins of the chronic myeloproliferative disorders: it all makes sense
Blood
2005
123
13
CCL3 (MIP-1α) plasma levels and the risk for disease progression in chronic lymphocytic leukemia
Blood
2011
112
14
Final results of a phase 1 study of loncastuximab tesirine in relapsed/refractory B-cell non-Hodgkin lymphoma
Blood
2021
111
15
CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia
Blood
2000
109
16
Anemia After Bariatric Surgery: More Than Just Iron Deficiency
Nutrition in Clinical Practice
2009
104
17
Lack of Allelic Exclusion in B Cell Chronic Lymphocytic Leukemia
Journal of Experimental Medicine
1997
98
18
Thrombopoietin enhances expression of vascular endothelial growth factor (VEGF) in primitive hematopoietic cells through induction of HIF-1α
Blood
2005
96
19
Etranacogene dezaparvovec (AMT-061 phase 2b): normal/near normal FIX activity and bleed cessation in hemophilia B
Blood Advances
2019
85
20
Successful Treatment of HIV-Associated Kaposi Sarcoma with Immune Checkpoint Blockade
Cancer Immunology Research
2018
81
21
Integrin αvβ3 Drives Slug Activation and Stemness in the Pregnant and Neoplastic Mammary Gland
Developmental Cell
2014
80
22
Latent sensitivity to Fas-mediated apoptosis after CD40 ligation may explain activity of CD154 gene therapy in chronic lymphocytic leukemia
Proceedings of the National Academy of Sciences of the United States of America
2002
78
23
COVID-19 vaccination and breakthrough infections in patients with cancer
Annals of Oncology
2022
76
24
Point‐of‐care musculoskeletal ultrasound is critical for the diagnosis of hemarthroses, inflammation and soft tissue abnormalities in adult patients with painful haemophilic arthropathy
Haemophilia
2015
72
25
Development of lentiviral vectors for gene therapy for human diseases
Blood
2000
68
26
PI3K/Akt/FOXO3a pathway contributes to thrombopoietin-induced proliferation of primary megakaryocytes in vitro and in vivo via modulation of p27Kip1
Cell Cycle
2008
65
27
Normal B Cells Express
51p1
-Encoded Ig Heavy Chains That Are Distinct From Those Expressed by Chronic Lymphocytic Leukemia B Cells
Journal of Immunology
2001
62
28
Development of lentiviral vectors for gene therapy for human diseases
Blood
2000
53
29
Post prostatectomy outcomes of patients with high-risk prostate cancer treated with neoadjuvant androgen blockade
Prostate Cancer and Prostatic Diseases
2018
48
30
Analysis of Tissue and Circulating Tumor DNA by Next-Generation Sequencing of Hepatocellular Carcinoma: Implications for Targeted Therapeutics
Molecular Cancer Therapeutics
2018
47
31
Immune-Related Pneumonitis After Chemoradiotherapy and Subsequent Immune Checkpoint Blockade in Unresectable Stage III Non–Small-Cell Lung Cancer
Clinical Lung Cancer
2020
46
32
Approaches to Gene Therapy for Human Immunodeficiency Virus Infection
Human Gene Therapy
2001
42
33
Genomic landscape of advanced basal cell carcinoma: Implications for precision treatment with targeted and immune therapies
OncoImmunology
2018
41
34
Introduction to retroviruses and retroviral vectors
Somatic Cell and Molecular Genetics
2001
38
35
Hyporesponsiveness to Erythropoiesis Stimulating Agents in Chronic Kidney Disease: The Many Faces of Inflammation
Advances in Chronic Kidney Disease
2009
35
36
Proton Pump Inhibitors and Survival Outcomes in Patients With Metastatic Renal Cell Carcinoma
Clinical Genitourinary Cancer
2017
34
37
GNAS, GNAQ,
and
GNA11
alterations in patients with diverse cancers
Cancer
2018
34
38
Role of ultraviolet mutational signature versus tumor mutation burden in predicting response to immunotherapy
Molecular Oncology
2020
33
39
Obesity Is an Independent Predictor of Poor Survival in Metastatic Breast Cancer: Retrospective Analysis of a Patient Cohort Whose Treatment Included High-Dose Chemotherapy and Autologous Stem Cell Support
International Journal of Breast Cancer
2011
31
40
Appearance of New Cutaneous Superficial Basal Cell Carcinomas during Successful Nivolumab Treatment of Refractory Metastatic Disease: Implications for Immunotherapy in Early Versus Late Disease
International Journal of Molecular Sciences
2017
31
41
Vascular Permeability and Remodelling Coincide with Inflammatory and Reparative Processes after Joint Bleeding in Factor VIII-Deficient Mice
Thrombosis and Haemostasis
2018
31
42
A Human Monoclonal Antibody Reactive with Human Prostate
Journal of Urology
1984
29
43
Tumor promotion by caspase-resistant retinoblastoma protein
Proceedings of the National Academy of Sciences of the United States of America
2005
29
44
SWI/SNF complex alterations as a biomarker of immunotherapy efficacy in pancreatic cancer
JCI Insight
2021
29
45
The Hypertension of Hemophilia Is Not Explained by the Usual Cardiovascular Risk Factors: Results of a Cohort Study
International Journal of Hypertension
2016
27
46
Immunodetection of cell-bound antigens using both mouse and human monoclonal antibodies
Journal of Immunological Methods
1985
26
47
Molecular Profiling of Tumor Tissue and Plasma Cell-Free DNA from Patients with Non-Langerhans Cell Histiocytosis
Molecular Cancer Therapeutics
2019
26
48
Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell–derived factor-1
Blood
2000
26
49
Improving research for prostate cancer survivorship: A statement from the Survivorship Research in Prostate Cancer (SuRECaP) working group
Urologic Oncology: Seminars and Original Investigations
2020
24
50
Molecular features of exceptional response to neoadjuvant anti-androgen therapy in high-risk localized prostate cancer
Cell Reports
2021
24
site/software ©
exaly
; All materials licenced under
CC by-SA
.